Shell Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,169
Closed -$61K 1154
2025
Q2
$61K Sell
6,169
-4,639
-43% -$45.4K ﹤0.01% 1110
2025
Q1
$101K Buy
10,808
+311
+3% +$3.27K ﹤0.01% 1015
2024
Q4
$96K Hold
10,497
﹤0.01% 1054
2024
Q3
$82K Buy
+10,497
New +$75.8K ﹤0.01% 1088
2024
Q1
$67K Sell
11,108
-1,442
-11% -$8.57K ﹤0.01% 1110
2023
Q4
$98K Sell
12,550
-3,807
-23% -$26.4K ﹤0.01% 1062
2023
Q3
$120K Sell
16,357
-255
-2% -$2.12K 0.01% 1044
2023
Q2
$173K Sell
16,612
-93
-0.6% -$895 0.01% 969
2023
Q1
$173K Sell
16,705
-58
-0.3% -$742 0.01% 975
2022
Q4
$231K Sell
16,763
-3,519
-17% -$49K 0.01% 893
2022
Q3
$415K Sell
20,282
-5,332
-21% -$117K 0.02% 664
2022
Q2
$496K Buy
25,614
+36
+0.1% +$737 0.01% 723
2022
Q1
$551K Sell
25,578
-3,787
-13% -$85.9K 0.01% 758
2021
Q4
$810K Buy
29,365
+152
+0.5% +$4.19K 0.02% 672
2021
Q3
$758K Sell
29,213
-1,260
-4% -$33.7K 0.02% 643
2021
Q2
$827K Buy
30,473
+1,650
+6% +$40.3K 0.02% 662
2021
Q1
$674K Sell
28,823
-160
-0.6% -$3.23K 0.01% 720
2020
Q4
$444K Hold
28,983
0.01% 845
2020
Q3
$350K Hold
28,983
0.01% 844
2020
Q2
$295K Buy
28,983
+3,722
+15% +$38.4K 0.01% 903
2020
Q1
$263K Sell
25,261
-385
-2% -$4.83K 0.01% 915
2019
Q4
$411K Sell
25,646
-681
-3% -$10.4K 0.01% 956
2019
Q3
$485K Sell
26,327
-225
-0.8% -$4.4K 0.01% 906
2019
Q2
$523K Sell
26,552
-607
-2% -$12.4K 0.01% 901
2019
Q1
$621K Buy
+27,159
New +$590K 0.01% 805

Other funds holding ANGO

Shell Asset Management's ANGO Position: Q3 2025 in Review

Shell Asset Management sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 6,169 shares — an estimated $61K sold.

Shell Asset Management first reported a position in ANGO in Q1 2019 and held it in 25 quarters. The position peaked at $827K in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Shell Asset Management reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Shell Asset Management sold 6,169 AngioDynamics shares in Q3 2025, an estimated $61K.
  • Shell Asset Management first reported a position in AngioDynamics in Q1 2019 and held it in 25 quarters.
  • Shell Asset Management's AngioDynamics position peaked at $827K in Q2 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.